Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants.

Trial Profile

Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants.

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 13 Nov 2012

At a glance

  • Drugs Ticarcillin/clavulanic acid (Primary)
  • Indications Bacterial infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 13 Nov 2012 Actual initiation date Sep 2010 added as reported by ClinicalTrials.gov.
    • 13 Nov 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 04 Oct 2012 Planned End Date changed from 1 Dec 2012 to 31 Dec 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top